90 minutes to Watch

This recorded webinar covers the introduction of the adalimumab biosimilar Amgevita in New Zealand, and what it means for primary care. Specialist Dr David Liew shares his experiences of changing patients from biologics to biosimilars in Australia, and Andrea Copeland provides some local context.

Dr David Liew, Andrea Copeland
17 March 2022
90 minutes to Watch

In this recorded webinar, Professor Lisa Stamp explores the management of gout as a long-term condition and challenges old beliefs. Dr Noni Richards introduces the EPiC Gout dashboard and outlines how it can be used to highlight and address inequities. 

Professor Lisa Stamp, Dr Noni Richards
25 February 2022
60 minutes to Watch

In this webinar, Dr Raewyn Fisher discusses the range of disease-modifying therapies that have improved heart failure outcomes, and provides reassurance around the funding changes to cilazapril.

Dr Raewyn Fisher
24 August 2021
65 minutes to Watch

In this webinar, Dr Ryan Paul discusses the changes to type 2 diabetes care in 2021, including when and how to use SGLT2 inhibitors and GLP-1 agonists. You can watch the webinar here or in ELearning. 

Downloadable empagliflozin patient information and a recent slide presentation can be found within this article.

Dr Ryan Paul
4 March 2021